Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
Research output: Contribution to journal › Journal article › Research › peer-review
Recent studies suggest that proton pump inhibitor treatment may increase insulin secretion and improve glucose metabolism in type 2 diabetes. In a randomised double-blind prospective placebo-controlled 2 × 2 factorial study, we examined the effect of esomeprazole on insulin secretion, HbA(1c) and cardiovascular risk factors in type 2 diabetes.
| Original language | English |
|---|---|
| Journal | Diabetologia |
| Volume | 56 |
| Issue number | 1 |
| Pages (from-to) | 22-30 |
| Number of pages | 9 |
| ISSN | 0012-186X |
| DOIs | |
| Publication status | Published - 2013 |
ID: 48605867